The Key Role of Regulatory Affairs in the Pharmaceutical Industry
Regulatory Affairs is about much more than getting a medicinal product approved. From early clinical development to market authorization and post-approval changes, regulatory decisions can shape the entire product lifecycle. Discover where RA adds value and why early involvement matters.
About This White Paper
Bringing a medicinal product from development to market is a lengthy, complex and costly process. Regulatory Affairs plays a crucial role throughout that journey, helping companies navigate regulatory requirements while keeping development and commercialization goals on track.
This white paper explores the role of Regulatory Affairs across the pharmaceutical product lifecycle. It looks at how RA contributes to clinical development strategy, supports interactions with competent authorities and helps determine the right pathway towards marketing authorization. It also explains the role of regulatory teams in preparing compliant dossiers and managing CMC information throughout development.
And the work doesn't stop once a product reaches the market. From variations and new filings to product classification changes, renewals and withdrawals, you'll discover why Regulatory Affairs remains essential throughout commercialization and lifecycle management.
Key Takeaways
-
Understand the Role of RA Across the Product Lifecycle. See how Regulatory Affairs supports a medicinal product from early development and clinical trials through approval, commercialization and post-approval changes.
-
Get Regulatory Input Early in Clinical Development. Learn why involving RA from the research stage can help shape the clinical development strategy, anticipate regulatory expectations and avoid unnecessary delays.
-
Navigate the Path to Marketing Authorization. Explore the different EU registration routes and the strategic considerations involved in choosing the appropriate submission pathway.
-
Build a Compliant Regulatory Dossier. Understand how Regulatory Affairs works alongside CMC and clinical experts to compile CTD and eCTD dossiers for submission to competent authorities.
-
Keep Your Marketing Authorization Up to Date. Discover how variations, new filings, renewals and other regulatory activities help maintain compliance as products and manufacturing processes evolve.
-
Think Beyond Approval. Learn why successful lifecycle management requires continued regulatory involvement long after commercialization begins, from expanding into new markets to managing post-approval changes.